These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23676509)

  • 21. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
    Wan DS; Wu XJ; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Ding PR
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3064-7. PubMed ID: 17288838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of multiple liver metastases after resection of gastrointestinal stromal tumor of the small intestine that was successfully treated with imatinib mesylate].
    Ebisui C; Okada K; Wada Y; Kato R; Makino S; Nishigaki T; Owada Y; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1708-10. PubMed ID: 24393896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate.
    Ferraresi V; Catricalà C; Ciccarese M; Ferrari A; Zeuli M; Cognetti F
    Anticancer Res; 2006; 26(6C):4771-4. PubMed ID: 17214339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
    Santachiara R; Maffei R; Martinelli S; Arcari A; Piacentini F; Trabacchi E; Alfieri P; Ferrari A; Leonardi G; Luppi G; Longo G; Vallisa D; Marasca R; Torelli G
    Haematologica; 2008 Aug; 93(8):1252-5. PubMed ID: 18519520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors.
    Cohen MH; Cortazar P; Justice R; Pazdur R
    Oncologist; 2010; 15(3):300-7. PubMed ID: 20200041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of recurrent gastrointestinal stromal tumor progressing after interruption of long-term imatinib therapy].
    Nakatsuka R; Takahashi T; Miyazaki Y; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2478-80. PubMed ID: 25731563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors.
    Tonyali O; Coskun U; Yildiz R; Karakan T; Demirci U; Akyurek N; Benekli M; Buyukberber S
    Med Oncol; 2010 Sep; 27(3):768-73. PubMed ID: 19662540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(®)) in a patient being treated for gastrointestinal stromal tumor (GIST).
    Gulati AP; Saif MW
    Anticancer Res; 2012 Apr; 32(4):1375-7. PubMed ID: 22493373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib-associated bilateral gynecomastia and unilateral testicular hydrocele in male patient with metastatic gastrointestinal stromal tumor: a literature review.
    Tanriverdi O; Unubol M; Taskin F; Meydan N; Sargin G; Guney E; Barutca S
    J Oncol Pharm Pract; 2012 Jun; 18(2):303-10. PubMed ID: 22009701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of gastrointestinal stromal tumor of the jejunum successfully treated by preoperative induction chemotherapy with imatinib mesylate administered through jejunostomy and subsequent surgical resection].
    Kimura H; Ohtsuka T; Toma H; Ueda J; Mizuuchi Y; Yamamoto H; Takahata S; Oda Y; Ueki T; Tanaka M
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):391-4. PubMed ID: 24743291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two cases of surgical resection of rectal gastrointestinal stromal tumor after neoadjuvant therapy with imatinib mesylate].
    Nakashima S; Fujita Y; Matsuo H; Ariyoshi Y; Fukuda K; Fujiyama J; Masuyama M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1932-4. PubMed ID: 23267934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report.
    Bongiovanni A; Ricci M; Riva N; Calpona S; Oboldi D; Pieri F; Cavaliere D; Mercatali L; Liverani C; La Manna F; De Vita A; Foca F; Gunelli E; Amadori D; Ibrahim T
    Future Oncol; 2014 Dec; 10(15):2423-7. PubMed ID: 25525851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour.
    Pariente A; Etcharry F; Cales V; Laborde Y; Ferrari S; Biour M
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):785-7. PubMed ID: 16772838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate].
    Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.
    Boruban C; Sencan O; Akmansu M; Atik ET; Ozbek S
    Anticancer Drugs; 2007 Sep; 18(8):969-72. PubMed ID: 17667604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of recurrent gastrointestinal stromal tumor with complete response from treatment with reduced dose of imatinib mesylate].
    Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Ikehara T; Sakashita K; Kanehara I; Teraoka H; Nishiguchi Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1723-5. PubMed ID: 23152028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A metastatic case of gastrointestinal stromal tumor (GIST) treated with imatinib mesylate (Glivec(®)) in Mali.
    Diallo DA; Ly M; Diallo G; Dembélé AK; Touré M; Touré BA; Koné A; Sidibé S; Dembelé M; Traore BC
    Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):675-7. PubMed ID: 21641899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug-induced pneumonia that may have been caused by imatinib mesylate administered for gastrointestinal stromal tumor].
    Iritani E; Kondo M; Kanemura T; Hara Y; Tagaya E; Tamaoki J; Nagai A
    Nihon Kokyuki Gakkai Zasshi; 2007 Jul; 45(7):577-81. PubMed ID: 17682471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
    Cohen MH; Farrell A; Justice R; Pazdur R
    Oncologist; 2009 Feb; 14(2):174-80. PubMed ID: 19193781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.